The UK register of HIV seroconverters: Methods and analytical issues

Epidemiology and Infection

Volumn 117, Issue 2, 1996, Pages 305-312

  Beral, V ^a   Babiker, A ^b   Breltle, R P ^c   Carne, C ^d   Darbyshire, J H ^b   Evans, B G ^e   Gilson, R J C ^f   Goldberg, D ^g   Hawkins, D A ^h   Jeffries, D ⁱ   Johnson, A M ^f   Johnson, M A ^j   McMichael, A J ^k   Mortimer, P P ^l   Phillips, A N ^j   Porter, K ^b,f   Pozniak, A ^m   Weber, J ⁿ   Wellsteed, S ^o  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g Scottish Centre for Infection and Environmental Health   (United Kingdom)

^h CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

ⁱ ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^j ROYAL FREE HOSPITAL   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^m KING S COLLEGE HOSPITAL   (United Kingdom)

ⁿ ST MARY S HOSPITAL   (United Kingdom)

^o United Kingdom Department of Health   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COMMUNICABLE DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; REGISTER; SEROCONVERSION; UNITED KINGDOM; VIRUS TRANSMISSION;

EID: 10244270764     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268800001485     Document Type: Article

References (28)

1. Hessol NA, Koblin BA, van Griensven GJP, et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994; 139: 1077-87.
2. Muǹoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicentre AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993: 137: 423-38.
3. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992; 340: 863-7.
4. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. New Engl J Med 1989; 321: 947-52.
5. Rosenberg PS, Goedert JJ, Biggar RJ, et al. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994; 8: 803-10.
6. Saah AJ, Muñoz A, Kuo V, et al. Predictors of the risk of development of Acquired Immunodeficiency Syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. Am J Epidemiol 1992; 135: 1147-55.
7. Margolick JB, Muñoz A, Vlahov D, et al. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992; 267: 1631-6.
8. Lang W, Perkins H, Anderson RE, et al. Patterns of T lymphocyte changes with human immunodeficiency virus infection : from seroconversion to the development of AIDS. J Acq Immun Defic Synd 1989; 2: 63-9.
9. Hessol NA, Lifson AR, O'Malley PM, et al. Prevalence, incidence and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol 1989; 130: 1167-75.
10. Gorham ED, Garland FC, Mayers DL, et al. CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Arch Intern Med 1993; 153: 869-76.
11. Schechter MT, Boyko WJ, Craib KJP, et al. Effects of long-term seropositivity to human immunodeficiency virus in a cohort of homosexual men. AIDS 1987; 1: 77-82.
12. Burcham J, Marmor M, Dubin N, et al. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5: 365-72.
13. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7: 51-7.
14. Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990; 4: 125-9.
15. Pedersen C, Lindhart Bø, Jensen BL, et al. Clinical course of primary infection: consequences for subsequent course of infection. BMJ 1989; 299: 154-7.
16. Darby SC, Rizza CR, Doll R, et al. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ 1989; 298: 1064-8.
17. Phillips AN, Sabin CA, Elford J, et al. Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection. BMJ 1994; 309: 309-13.
18. Brettle RP, McNeil AJ, Gore SM, et al. The Edinburgh City Hospital cohort analysis of enrolment, progression and mortality by baseline covariates. QJM 1995 ; 88 (7) : 479-91.
19. Msellati P, Dupon M, Morlat P, et al. A cohort of 89 HIV-1 infected adult patients contaminated by blood products: Bordeaux 1981-1989. AIDS 1990; 4: 1105-9.
20. Chiarotti F, Palombi M, Schinaia N, et al. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs : different parametric estimates. Stat Med 1994; 13: 163-75.
21. Lepri AC, Pezzotti P, Dorrucci M, et al. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Br Med J 1994; 309: 1537-42.
22. Veugelers PJ, Page KA, Tindall B, et al. Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconverter study. Am J Epidemiol 1994; 140: 747-58.
23. Ancelle-Park RA. European AIDS definition. Lancet 1992; 339: 671.
24. Report of an expert group (Chairman, Professor NE Day) convened by the Director of the Public Health Laboratory Service on behalf of the Chief Medical Officers. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995-1999: projections using data to the end of 1994. CDR 1996; 6.
25. Report of a Working Group convened by the Chief Medical Officer for Scotland December 1995. AIDS and severe HIV-related disease in Scotland. Predictions to the end of 1999. ANSWER, 29 December 1995.
26. AIDS and HIV-1 infection in the United Kingdom: monthly report. CDR, 1996; 6: 25-8.
27. Hendriks JCM, Medley GF, van Griensven GJP, et al. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 1993; 7: 231-9.
28. Kuo J-M, Taylor JMG, Detels R. Estimating the AIDS incubation period from a prevalent cohort. Am J Epidemiol 1991; 133: 1050-7.